Study seeks to understand how different forms of data meet the needs of researchers.
Peter Mesenbrink
Advertisement
Peter Mesenbrink, Executive Director, Biostatistics, Novartis
Articles by Peter Mesenbrink
Advertisement
Latest Updated Articles
- Establishing a Basis for Secondary Use Standards for Clinical Trials
Published: March 8th 2023 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
